中文 | English
Return
Total: 288 , 1/29
Show Home Prev Next End page: GO
Author:(Xue-Juan YU)

1. Treatment outcomes and safety of sequential administration of erlotinib following chemotherapy in patients with erlotinib (as second-line treatment)-resistant advanced non-small cell lung cancer

Xue-Juan YU

Tumor 2013;33(11):1002-1007

2.Clinical Efficacy of Levofloxacin and Azithromycinin in the Treatment of Mycoplasma Pneumonia

Sijing LU ; Yu LIU ; Juan DU ; Xue JIAO

China Pharmacy 2007;0(28):-

4.A clinical study of low frequency electric stimulation on the patients with vertebrobasUar insufficiency

Xue-Yuan LIU ; Jing HUANG ; Ke LIU ; Yu-Juan CHEN ;

Chinese Journal of Physical Medicine and Rehabilitation 2003;0(06):-

6.Chemical comparison of different Farfarae Flos by NMR-based metabolomic approaches.

Zheng-zheng ZHANG ; Hai-juan ZHI ; Xue-mei QIN ; Zhen-yu LI

Acta Pharmaceutica Sinica 2015;50(5):599-604

8.Expression of miR-155 in peripheral blood and skin lesions from as well as its relationship with Th17 cells in patients with atopic dermatitis

Lei MA ; Haibo XUE ; Xiuhao GUAN ; Chunmei SHU ; Juan YU ; Junhua ZHANG ; Beilei YUN

Chinese Journal of Dermatology 2014;47(1):15-18

9.Effects of intracerebroventricular microinjection of L-arginine on exercise capacity and expression of nitric oxide in rat hypothalamus.

Jin-Juan XUE ; Hong-Yu LIU

Chinese Journal of Applied Physiology 2013;29(2):158-161

10. Accelerated hypofractionated 3-dimensional conformal radiotherapy vs conventional radiotherapy in locally advanced non-small cell lung cancer using PET/CT-derived plan: A prospectively randomized controlled trial

Xue-Juan YU

Tumor 2014;34(3):253-259

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 288 , 1/29 Show Home Prev Next End page: GO